FORA
Forian Inc.
$2.18
+$0.05(+2.35%)
39
Overall
60
Value
18
Tech
--
Quality
Market Cap
$68.76M
Volume
31.59K
52W Range
$1.64 - $4.03
Target Price
$5.00
Company Overview
| Mkt Cap | $68.76M | Price | $2.18 |
| Volume | 31.59K | Change | +2.35% |
| P/E Ratio | -18.2 | Open | $2.13 |
| Revenue | $20.2M | Prev Close | $2.13 |
| Net Income | $-3.8M | 52W Range | $1.64 - $4.03 |
| Div Yield | N/A | Target | $5.00 |
| Overall | 39 | Value | 60 |
| Quality | -- | Technical | 18 |
No chart data available
About Forian Inc.
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharma services, and healthcare payer and provider industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Latest News
VerticalScope Holdings (FORA) was downgraded to a Hold Rating at Canaccord Genuity
TipRanks Auto-Generated Intelligence Newsdesk•13 days ago
RBC Capital Keeps Their Hold Rating on VerticalScope Holdings (FORA)
TipRanks Auto-Generated Intelligence Newsdesk•24 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FORA | $2.18 | +2.3% | 31.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |